"ctDNA as a minimal residual disease biomarker after curative-intent pancreatic cancer resection" OR "ctDNA as a prognostic biomarker after curative-intent pancreatic cancer resection — systematic review and meta-analysis" would you recommend the below to be a good meta-analysis focused topic with good impact and feasibility
Searching PubMed
ctDNA minimal residual disease pancreatic cancer resection
Searching PubMed
circulating tumor DNA pancreatic cancer prognosis surgery meta-analysis
Searching the Web
ctDNA MRD pancreatic cancer resection systematic review meta-analysis 2024 2025
Reading Article
Reading Article
Searching PubMed
ctDNA postoperative pancreatic cancer recurrence prognosis 2024 2025
Searching PubMed
ctDNA pancreatic ductal adenocarcinoma postoperative prognosis recurrence
Searching the Web
ctDNA MRD pancreatic cancer adjuvant therapy RCT 2025 2026 clinical trial
Your credits are exhausted. You can purchase a top-up or subscribe to a plan to continue using Orris. If you're already subscribed, your daily credits will reset tomorrow.
This is a shared conversation. Sign in to Orris to start your own chat.